Akoya Biosciences, Inc. - Prakiraan wutah bathi resik saben saham kanggo taun ngarep AKYA

Simbol lan logo merek Akoya (AKYA)

Akoya Biosciences dominates biomarker analysis, creating a barrier to entry for competitors through proprietary materials. After evaluating the projected EPS growth rate for next year on GURU.Markets, we find that 16.90 reflects the latest metric value. The business relies on the recognition of its technologies in oncology and the volume of reagent consumption. The model scales through instrument installations, which ensure a steady stream of high-margin revenue.

AKYA: Prakiraan wutah bathi resik saben saham ing taun ngarep Akoya Biosciences Inc 04.07.2022 - 19.07.2025

AKYA (Akoya Biosciences Inc): rincian analitis lan laporan miturut indikator

Analisis komprehensif perusahaan:akoyabio.com, AKYA
Produk dadi Akoya Biosciences, Inc.

This indicator reflects the consensus forecast for net earnings per share changes, allowing for an assessment of the recovery speed of profitability and the identification of long-term trend reversals. By comparing different issuers through the evaluation of the annual EPS growth for the next period, an investor can confirm the monetization of the B2B market's high confidence in Akoya Biosciences (AKYA) spatial biology technologies and its leadership in tissue analysis.

Pesaing utama

Prakiraan wutah bathi resik saben saham kanggo taun ngarep abbott.com|Prakiraan wutah bathi saben saham kanggo taun ngarep Thermo Fisher Scientific (TMO)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep GE HealthCare Technologies Inc. (GEHC)|MTD - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep WAT (Waters Corporation)|Techne Corporation (TECH) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Bruker - Prakiraan wutah bathi kanggo taun ngarep|AZTA (Azenta, Inc.) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|VREX: Prakiraan wutah bathi kanggo taun ngarep|SMLR - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|BFLY (Butterfly Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Mesa Labs Corp (MLAB)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Quantum-Si (QSI)|Prakiraan wutah bathi kanggo taun ngarep nanox.vision (NNOX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Quanterix QTRX|908 Devices Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CV - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep MXCT (MaxCyte, Inc)|RPID: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep seer.bio (SEER)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep hyperfine.io|FONR - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep DXR|Prakiraan wutah bathi kanggo taun ngarep Spectral AI, Inc. (MDAI)|Prakiraan wutah bathi kanggo taun ngarep VIVS (Organovo Holdings Inc.)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep aclarion.com (ACON)|THMO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep TLIS|T2 Biosystems Inc (TTOO) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep